MAM
MDCO

Martingale Asset Management’s Medicines Co MDCO Stock Holding History

Martingale Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-25,409
Closed -$727K – 910
2015
Q2 		$727K Sell
25,409
-14,200
-36% -$396K 0.02% 604
2015
Q1 		$1.11M Buy
39,609
+5,995
+18% +$168K 0.03% 489
2014
Q4 		$931K Sell
33,614
-10,408
-24% -$258K 0.03% 544
2014
Q3 		$983K Sell
44,022
-12,893
-23% -$327K 0.03% 495
2014
Q2 		$1.65M Buy
56,915
+24,005
+73% +$641K 0.05% 353
2014
Q1 		$936K Buy
32,910
+7,107
+28% +$235K 0.03% 516
2013
Q4 		$997K Buy
25,803
+4,696
+22% +$168K 0.03% 548
2013
Q3 		$708K Sell
21,107
-4,803
-19% -$153K 0.03% 653
2013
Q2 		$797K Buy
+25,910
New +$867K 0.03% 597

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Martingale Asset Management's MDCO Position: Q3 2015 in Review

Martingale Asset Management sold out of Medicines Co (MDCO) in Q3 2015, closing a stake of 25,409 shares — an estimated $727K sold.

Martingale Asset Management first reported a position in MDCO in Q2 2013 and held it in 9 quarters. The position peaked at $1.65M in Q2 2014. 183 funds tracked by Wall St. Rank hold MDCO as of Q3 2015.

  • Martingale Asset Management reported no remaining Medicines Co position as of Q3 2015 after selling out during the quarter.
  • Martingale Asset Management sold 25,409 Medicines Co shares in Q3 2015, an estimated $727K.
  • Martingale Asset Management first reported a position in Medicines Co in Q2 2013 and held it in 9 quarters.
  • Martingale Asset Management's Medicines Co position peaked at $1.65M in Q2 2014.
  • 183 funds tracked by Wall St. Rank held Medicines Co as of Q3 2015.

Based on Martingale Asset Management's 13F filing for Q3 2015, filed 12 Nov 2015.